| Gary T Fischbach, MD | |
|
6124 Woodside Executive Ct, Aiken, SC 29803-3820 | |
| (803) 226-0112 | |
| (803) 226-0132 |
| Full Name | Gary T Fischbach |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 6124 Woodside Executive Ct, Aiken, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174589204 | NPI | - | NPPES |
| 107583 | Medicaid | SC | |
| 562134996 | Other | SC | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0502521 (South Carolina) | Secondary |
| 207R00000X | Internal Medicine | 10758 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gary T Fischbach, MD 6124 Woodside Executive Ct, Aiken, SC 29803-3820 Ph: (803) 226-0112 | Gary T Fischbach, MD 6124 Woodside Executive Ct, Aiken, SC 29803-3820 Ph: (803) 226-0112 |
News Archive
Preliminary findings from two analyses of an ongoing study suggest that cognitive behavioral therapy for insomnia delivered by telemedicine is as effective as face-to-face delivery.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement") with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.
Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people.
› Verified 9 days ago
Kate Barrett Mayes, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 223 Park Ave Se, Aiken, SC 29801 Phone: 803-641-1270 Fax: 803-641-1276 | |
Thomas Mccullough, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 University Pkwy Ste 2500, Aiken, SC 29801 Phone: 803-648-7888 Fax: 803-648-3302 | |
Ghulam Murtaza, Internal Medicine Medicare: Medicare Enrolled Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 | |
Janet L Utz, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 137 Miracle Drive, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Keifer Dewayne Richardson, PA-C Internal Medicine Medicare: Medicare Enrolled Practice Location: 526 Richland Ave W, Aiken, SC 29801 Phone: 803-648-3130 | |
Dr. Weems R Pennington Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 137 Miracle Dr, Aiken, SC 29801 Phone: 803-641-4874 Fax: 803-641-0436 | |
Dr. Frank Joseph Mondschein, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 102 Summerwood Way, Aiken, SC 29803 Phone: 803-649-5300 Fax: 803-649-0056 |